Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 1
2021 2
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
The role of gut microbiota in Clostridium difficile infection.
Samarkos M, Mastrogianni E, Kampouropoulou O. Samarkos M, et al. Among authors: mastrogianni e. Eur J Intern Med. 2018 Apr;50:28-32. doi: 10.1016/j.ejim.2018.02.006. Epub 2018 Feb 7. Eur J Intern Med. 2018. PMID: 29428498 Review.
Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study.
Georgakopoulou VE, Gkoufa A, Makrodimitri S, Basoulis D, Tsakanikas A, Karamanakos G, Mastrogianni E, Voutsinas PM, Spandidos DA, Papageorgiou CV, Gamaletsou MN, Sipsas NV. Georgakopoulou VE, et al. Among authors: mastrogianni e. Exp Ther Med. 2023 Aug 9;26(4):462. doi: 10.3892/etm.2023.12161. eCollection 2023 Oct. Exp Ther Med. 2023. PMID: 37664680 Free PMC article.
Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study.
Basoulis D, Tsakanikas A, Gkoufa A, Bitsani A, Karamanakos G, Mastrogianni E, Georgakopoulou VE, Makrodimitri S, Voutsinas PM, Lamprou P, Kontos A, Tsiakas S, Gamaletsou MN, Marinaki S, Sipsas NV. Basoulis D, et al. Among authors: mastrogianni e. Viruses. 2023 Jul 7;15(7):1515. doi: 10.3390/v15071515. Viruses. 2023. PMID: 37515201 Free PMC article.
Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection.
Psichogiou M, Karabinis A, Poulakou G, Antoniadou A, Kotanidou A, Degiannis D, Pavlopoulou ID, Chaidaroglou A, Roussos S, Mastrogianni E, Eliadi I, Basoulis D, Petsios K, Leontis K, Kakalou E, Protopapas K, Jahaj E, Pratikaki M, Syrigos KN, Lagiou P, Gogas H, Tsiodras S, Magiorkinis G, Paraskevis D, Sypsa V, Hatzakis A. Psichogiou M, et al. Among authors: mastrogianni e. Vaccines (Basel). 2021 Sep 13;9(9):1017. doi: 10.3390/vaccines9091017. Vaccines (Basel). 2021. PMID: 34579254 Free PMC article.
Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study.
Diamantopoulos PT, Stafylidis C, Vlachopoulou D, Kontandreopoulou CN, Giannakopoulou N, Vardaka M, Mpouhla A, Mastrogianni E, Variami E, Galanopoulos A, Pappa V, Psichogiou M, Hatzakis A, Viniou NA. Diamantopoulos PT, et al. Among authors: mastrogianni e. Ther Adv Hematol. 2022 May 23;13:20406207221090150. doi: 10.1177/20406207221090150. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35646300 Free PMC article.
Comparison of Integrase Strand Transfer Inhibitors (INSTIs) and Protease-Boosted Inhibitors (PIs) on the Reduction in Chronic Immune Activation in a Virally Suppressed, Mainly Male Population Living with HIV (PLWH).
Nitsotolis T, Kyriakoulis KG, Kollias A, Papalexandrou A, Kalampoka H, Mastrogianni E, Basoulis D, Psichogiou M. Nitsotolis T, et al. Among authors: mastrogianni e. Medicina (Kaunas). 2024 Feb 15;60(2):331. doi: 10.3390/medicina60020331. Medicina (Kaunas). 2024. PMID: 38399618 Free PMC article.